Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP – Get Rating)’s share price crossed above its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of $5.79 and traded as high as $10.20. Corbus Pharmaceuticals shares last traded at $9.01, with a volume of 115,160 shares traded. Analyst Upgrades and Downgrades Several […]
Corbus Pharmaceuticals (NASDAQ:CRBP – Get Rating) and Aravive (NASDAQ:ARAV – Get Rating) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, valuation, analyst recommendations, institutional ownership, profitability, dividends and earnings. Profitability This table compares Corbus Pharmaceuticals and Aravive’s net margins, […]
StockNews.com initiated coverage on shares of Corbus Pharmaceuticals (NASDAQ:CRBP – Get Rating) in a research report issued to clients and investors on Wednesday. The brokerage set a “hold” rating on the biopharmaceutical company’s stock. Separately, Zacks Investment Research upgraded shares of Corbus Pharmaceuticals from a “hold” rating to a “buy” rating and set a $0.50 […]
StockNews.com started coverage on shares of Corbus Pharmaceuticals (NASDAQ:CRBP – Get Rating) in a report released on Saturday. The firm set a “hold” rating on the biopharmaceutical company’s stock. Separately, Zacks Investment Research upgraded Corbus Pharmaceuticals from a “hold” rating to a “buy” rating and set a $0.50 price objective for the company in a […]
Corbus Pharmaceuticals (NASDAQ:CRBP – Get Rating) posted its quarterly earnings data on Tuesday. The biopharmaceutical company reported ($0.08) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.11) by $0.03, MarketWatch Earnings reports. Corbus Pharmaceuticals had a negative return on equity of 55.63% and a negative net margin of 2,856.56%. NASDAQ CRBP […]